|Publication number||US3674013 A|
|Publication date||Jul 4, 1972|
|Filing date||Sep 30, 1970|
|Priority date||Sep 30, 1970|
|Also published as||CA943834A, CA943834A1, DE2132864A1|
|Publication number||US 3674013 A, US 3674013A, US-A-3674013, US3674013 A, US3674013A|
|Inventors||Michael L Polanyl|
|Original Assignee||American Optical Corp|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (6), Referenced by (69), Classifications (10), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent Polanyl a  FIBEROPTIC CATHETER  Inventor: Michael L. Polanyl, Webster, Mass. I
731 Assignee: American Optical Southbridge, Mass.
22 Filed: Sept. 30, 1970 21 Appl.No.: 76,714
1521 u.s. c1. ..12s/2.0s o, 128/2 R, 128/6,
' 350/96 B, 356/241 1511 1111.0. ..A6lb 05/02 58 1 Field of-Search ...128/2 R, 2 1., 2 M, 2.05 1),
 9 References Cited UNITED STATES PATENTS 3,335,715 8/1967 Hugenholtz et al. ..128/2 L 1 3,279,460 10/ 1966 Sheldon ..128/6 3,249,105 5/1966 Polanyi ..128/2.05 D
1451 July 4,1972
3,068,739 12/1962 Hicks et al. ..128/6 X 3,349,762 10/1967 Kapany ...l28/2.05 F 3,267,932 8/1966 Valliere ..128/2.05 D
Primary Examiner- Dalton L. Truluck Attorney-William C. Nealon, Noble S. Williams and Robert J. Bird [5 7] ABSTRACT A fiberoptic catheter for monitoring blood in vivo with avoidance -of thrombus formation. A standard cardiac catheter having longitudinally extending afferent and efferent light-conducting fibers therewithin is terminated with a smoothly rounded tip. Some distance back from the tip, the
fibers are directed right-angularly to one side of the catheter where ends thereof are optically finished to fonn an exposed light-emitting and light-receiving face at said side of the catheter. This face is spaced from walls of passages of the recipient by a fixed bend in the adjacent terminal portion of the catheter.
. 5 Claims, 4 Drawing Figures PATENTEDJUL 4|s72 3,674,013
MICHAEL L. POLANY| FIBEROPTIC CATHETER BACKGROUND OF THE INVENTION 1. Field of the Invention Fiberoptic devices with particular reference to catheters having light-conducting fibers extending longitudinally internally through at least a substantial portion of their lengths.
2. Description of the Prior Art A main obstacle for the use of indwelling fiberoptic catheters is thrombus formation and/or an accumulation of fibrin around or adjacent to the effective light-emitting and light-receiving distal ends of the catheters. This usually results from irregularities in the construction of the catheter ends particularly in cases where cages and the like are used to prevent these ends from coming into too close proximity with the walls of body organs or passages into which the catheters are inserted.
Heretofor, the construction of fiberoptic catheters has necessitated the use of wire cages and the like to avoid the adverse effects of the observing ends of the catheters coming into too close proximity to the walls of passages into which the catheters are inserted. The undesireable effects of this too close proximity which are referred to in the art as wall effects, are false or unreliable readings of blood oxygen saturation, in the case in vivo oximeters, and similar unreliable indications of intravascular blood pressure and the like, in the case of fiberoptic intravascular pressure and sound determining catheter systems.
The present invention deals with the avoidance of thrombus formation, fibrin accumulation and wall effects in the use of indwelling fiberoptic catheters.
SUMMARY OF THE INVENTION In its relationship to the aforementioned matters, the present invention accomplishes its objectives through the provision of a standard cardiac catheter having longitudinally extending afferent and efferent light-conducting fibers therewithin. The catheter is terminated with a smoothly rounded tip some distance back from which the fibers are directed right-angularly to one side of the catheter. Ends of the fibers thus form a light-emitting and light-receiving face at the side of the catheter. This face is smoothly contoured into the corresponding side of the catheter and provides a lightemitting and light-receiving pickup area on the catheter. This smoothly contoured pickup area and rounded tip of the catheter renders the catheter readily insertable into the body and capable of being held in situ for long periods of time without thrombus formation or fibrin accumulation therearound. Additionally, the present catheter is provided with a fixed bend adjacent its terminal end which is directed arcuately along the side of the catheter having the aforesaid pickup area so that the pickup area is held at all times, in spaced relationship with walls or sides of body organs or passageways under observation.
The invention will be more fully understood by reference to the following detailed description and the accompanying drawing.
DESCRIPTION OF THE INVENTION DESCRIPTION OF THE PREFERRED EMBODIMENTS Fiberoptic catheter 10 comprises a length of standard cardiac catheter tubing 12 having a relatively short section 12a of its distal portion separated from its main section 12b by a rigid tubular internal coupling 14 which connects these sections 12a and 12b coaxially together. I
A bundle 16 of afferent and efferent light-conducting fibers 18 having a relatively sharp right-angular bend 20 (FIG. 3) adjacent its terminus is extended through the major portion of the length of catheter tubing 12 with its terminus directed laterally through a slot 22 in fitting 14. This extremity of fiber bundle 16 is fixedly secured within fitting 14 with an epoxy resin or similar adhesive potting agent 24 which, at the side of face 26 of bundle l6, smoothly fills in the gap between adjacent ends of section and 12b of catheter tubing 12. Also smoothly filling in the remaining spacing between sections 120 and 12b of catheter tubing 12 is a split collar 28 which extends from opposite sides of face 26 circumferentially about fitting 14 Face 26 of fiber bundle l6 and its surrounding exposed portions of the potting agent 24, as well as collar 28, are all smoothly externally finished and tightly joined to each other and to sections 12a and 12b of catheter tubing 12 so that the joinder of such sections 12a and 12b is continuous and the tendency for thrombus formation and/or fibrin accumulation thereabout is avoided.
In further avoiding thrombus formation along catheter tubing 12, its distal end is closed with a smoothly finished semispherical tip 30. In the particular embodiment of the invention herein illustrated, tip 30 is formed of metal having an electrical lead 32 connected thereto. Lead 32'extends externally of catheter 10 to a source of electrical current (not shown) which may be used to electrically stimulate the portion of a body (e.g. the heart) into which tip 30 is placed.
According to generally standard practice in applying fiberoptic catheters to associated light-emitting and light-receiving apparatuses, catheter tubing 12 is coupled to a larger tubing 34 (FIG. 1) which, in turn, is coupled to a Y-junction block 36. Bundle 16 is continued from catheter tubing 12 through tubing 34 and then separated into two legs within block 36. Each leg is directed separately outwardly of block 36 through respective relatively short lengths of tubings 38 and 40 and into corresponding end fittings 42 and 44. The particular fibers terminating in fitting 44 may be selected for transmitting light from a source 46 afferently through catheter 10 while the fibers terminating in fitting 42 function as the efferent fibers of catheter 10 which are used to conduct light to a photodetector 48.
Those interested in actual applications of devices such as catheter 10 may refer to U.S. Pat. Nos. 3,069,739; 3,068,742 and 3,461,856, for example. In the present case, however, the light-receiving and light-emitting face 26 of catheter 10 is disposed at a side of the catheter tubing whereby light emitted from catheter 10 is directed laterally of the tubing generally as illustrated by lines 50 (FIG. 2) which represent light rays.
In order to maintain a spacing between face 26 and the walls of passageway 52 (FIG. 3) which is sufficient to permit a free flow of blood over face 26 in the passageway, the end of catheter 10 is provided with a bend as indicated by arrow 54 in FIG. 2. Having its approximate center of curvature 56 disposed forwardly of face 26, this bend acts to prevent collapse of the walls of passageway 52 against the catheter. Thus, adequate spacing between face 26 and the walls of passageway 52 is maintained at all times during insertion of the catheter into the body and while in situ.
In order to assure a permanent setting of this bend in the catheter, its distal end is preferably placed within a rigid arcuately shaped tubular keeper 58 (FIG. 4) whenever the catheter is not is use.
Modifications of the present invention may include the addition of a flexible tubule within the catheter tubing 12 for sampling or otherwise monitoring body fluids in and around the distal end of catheter 10. Such a tubule or capillary (not shown) would of course have one end extended through a side of catheter 10 for communicating with body fluids and the like externally of the catheter. A thin sleeve of translucent material (also not shown) may be placed over face 26 of the catheter should it be desired to have the light emitted from face 26 diffused into a specimen fluid, e.g. blood.
1. In a fiber optic catheter including a catheter tubing having a bundle of light-conducting fibers extending longitudinally thereinto, the improvement comprising:
one end of said bundle of fibers being relatively sharply directed right-angularly within said catheter toward an outer side thereof and brought to a terminus disposed in exposed flush relationship with said outer side of said catheter;
means securing said one end of said fiber bundle fixedly in said catheter; and
said catheter tubing having a section being extended beyond said end of said fiber bundle arcuately about a bend having a center of curvature located approximately forwardly of said exposed terminus of said fiber bundle said section having a closed terminus and further being set to substantially permanently retain said arcuate shape of said bend.
2. In a fiberoptic catheter including a catheter tubing having a bundle of light-conducting fibers extending longitudinally thereinto, the improvement comprising:
said catheter tubing including a main section through which said bundle of light-conducting fibers extends, one end of said bundle of fibers being relatively sharply directed right-angularly within said catheter toward an outer side thereof and brought to a terminus disposed in exposed flush relationship with said other side of said catheter;
said catheter tubing further including a separate shorter section which comprises an extension beyond said one end of said fiber bundle; the terminus of said shorter section of tubing being closed;
a tubular coupling internally of said catheter tubing connecting said main and shorter sections thereof together; means securing said one end of said fiber bundle fixedly in said catheter; and
said shorter section of catheter tubing being extended beyond said one end of said fiber bundle arcuately about a bend having a center of curvature located approximately forwardly of said exposed fiber bundle terminus.
3. A fiberoptic catheter according to claim 2 wherein the temiinus of said shorter section of catheter tubing is closed by an attached smoothly rounded metallic tip and said catheter further includes an electrical lead affixed to said tip and extending efferently therefrom through said catheter.
4. A fiberoptic catheter according to claim 2 wherein said coupling has an opening in one side thereof through which said one end of said bundle of fibers is extended into said exposed flush relationship with said outer side of said catheter.
5. A fiberoptic catheter according to claim 4 wherein said securing means comprises an adhesive potting agent within said coupling, said agent extending around said terminus of said fiber bundle into smoothly finished flush relationship with adjacent outer sides of said main and shorter sections of said catheter tubing.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3068739 *||Jun 23, 1958||Dec 18, 1962||American Optical Corp||Flexible optical probe|
|US3249105 *||Apr 19, 1963||May 3, 1966||American Optical Corp||Devices for measuring blood pressure|
|US3267932 *||Nov 13, 1962||Aug 23, 1966||American Electronic Lab||Optical catheter means|
|US3279460 *||Dec 4, 1961||Oct 18, 1966||Emanuel Sheldon Edward||Endoscopes|
|US3335715 *||Sep 18, 1964||Aug 15, 1967||American Optical Corp||Fiber optic catheter|
|US3349762 *||Oct 21, 1964||Oct 31, 1967||Optics Technology Inc||Blood flow indicator and process|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3807390 *||Dec 4, 1972||Apr 30, 1974||American Optical Corp||Fiber optic catheter|
|US3809066 *||Feb 3, 1972||May 7, 1974||D Krawitt||Medical sensor device for locating calculi in body cavities|
|US3912574 *||Oct 24, 1974||Oct 14, 1975||Bell Telephone Labor Inc||Apparatus for splicing pairs of arrayed or individual fibers utilizing optical fiber aligning grooves|
|US3919037 *||Nov 7, 1974||Nov 11, 1975||Bell Telephone Labor Inc||Optical fiber splicing apparatus|
|US4412825 *||Sep 17, 1981||Nov 1, 1983||Tokarz Richard D||Medical entry connector for teeth bearing animals|
|US4444185 *||Aug 19, 1981||Apr 24, 1984||Shugar Martin A||Fiberoptic tracheotomy method|
|US4570638 *||Oct 14, 1983||Feb 18, 1986||Somanetics Corporation||Method and apparatus for spectral transmissibility examination and analysis|
|US4697593 *||Jun 25, 1985||Oct 6, 1987||Evans John M||Method and apparatus for measuring blood oxygen levels|
|US4817623||Feb 18, 1986||Apr 4, 1989||Somanetics Corporation||Method and apparatus for interpreting optical response data|
|US4824789 *||Oct 10, 1986||Apr 25, 1989||Cardiovascular Devices, Inc.||Gas sensor|
|US4830013 *||Jan 30, 1987||May 16, 1989||Minnesota Mining And Manufacturing Co.||Intravascular blood parameter measurement system|
|US4867919 *||Jan 26, 1989||Sep 19, 1989||Minnesota Mining And Manufacturing Company||Method of making a gas sensor|
|US4870952 *||Oct 28, 1983||Oct 3, 1989||Miquel Martinez||Fiber optic illuminator for use in surgery|
|US4928694 *||Mar 23, 1989||May 29, 1990||Minnesota Mining And Manufacturing Company||Intravascular blood parameter measurement system|
|US4934369 *||Mar 23, 1989||Jun 19, 1990||Minnesota Mining And Manufacturing Company||Intravascular blood parameter measurement system|
|US4951669 *||Aug 8, 1988||Aug 28, 1990||Minnesota Mining And Manufacturing Company||Blood parameter measurement system|
|US4989606 *||Aug 8, 1988||Feb 5, 1991||Minnesota Mining And Manufactoring Company||Intravascular blood gas sensing system|
|US5005576 *||Mar 30, 1989||Apr 9, 1991||Hewlett-Packard Company||Optical probe|
|US5020537 *||Mar 20, 1989||Jun 4, 1991||Hewlett-Packard Company||Measuring probe|
|US5041108 *||Jun 9, 1989||Aug 20, 1991||Pillco Limited Partnership||Method for laser treatment of body lumens|
|US5048525 *||Jun 18, 1990||Sep 17, 1991||Minnesota Mining And Manufacturing Company||Blood parameter measurement system with compliant element|
|US5058586 *||Jul 22, 1988||Oct 22, 1991||Siemens Aktiengesellschaft||Catheter for implantation in the heart, having an integrated measuring probe|
|US5140989 *||Feb 10, 1986||Aug 25, 1992||Somanetics Corporation||Examination instrument for optical-response diagnostic apparatus|
|US5175016 *||Mar 20, 1990||Dec 29, 1992||Minnesota Mining And Manufacturing Company||Method for making gas sensing element|
|US5188634 *||Jul 13, 1990||Feb 23, 1993||Trimedyne, Inc.||Rotatable laser probe with beveled tip|
|US5195963 *||Jan 14, 1992||Mar 23, 1993||Minnesota Mining And Manufacturing Company||Method and system for monitoring of blood constituents in vivo|
|US5265606 *||Feb 25, 1993||Nov 30, 1993||C. R. Bard, Inc.||System and technique for measuring blood characteristics by centering a sensor in an artery|
|US5284138 *||Jul 9, 1991||Feb 8, 1994||C. R. Bard, Inc.||Apparatus and method for positioning a sensor away from the blood vessel wall|
|US5284775 *||Sep 21, 1992||Feb 8, 1994||Minnesota Mining And Manufacturing Company||Gas sensing element and method for making same|
|US5335305 *||Oct 23, 1992||Aug 2, 1994||Optex Biomedical, Inc.||Optical sensor for fluid parameters|
|US5335658 *||Jun 29, 1992||Aug 9, 1994||Minnesota Mining And Manufacturing Company||Intravascular blood parameter sensing system|
|US5345932 *||Jan 15, 1993||Sep 13, 1994||Minnesota Mining And Manufacturing Company||Method and system for monitoring of blood constituents in vivo|
|US5349961 *||Jul 8, 1993||Sep 27, 1994||Somanetics Corporation||Method and apparatus for in vivo optical spectroscopic examination|
|US5397411 *||Dec 19, 1991||Mar 14, 1995||Optex Biomedical, Inc.||Method for making optical probe|
|US5421328 *||May 20, 1994||Jun 6, 1995||Minnesota Mining And Manufacturing Company||Intravascular blood parameter sensing system|
|US5462052 *||Apr 27, 1993||Oct 31, 1995||Minnesota Mining And Manufacturing Co.||Apparatus and method for use in measuring a compositional parameter of blood|
|US7241287||May 26, 2006||Jul 10, 2007||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Implanted surgical drain with drain holes for monitoring internal tissue condition|
|US7244251||Feb 9, 2004||Jul 17, 2007||Alfred E. Mann Institute For Biomedical Engineering||Implanted surgical drain with multiple sensing elements for monitoring internal tissue condition|
|US7252659||Feb 9, 2004||Aug 7, 2007||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Implanted surgical drain with sensing and transmitting elements for monitoring internal tissue condition|
|US7264616||May 26, 2006||Sep 4, 2007||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Method of utilizing a surgical drain with sensors for monitoring internal tissue condition|
|US7322971 *||Feb 9, 2004||Jan 29, 2008||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Surgical drain with sensors for monitoring internal tissue condition by transmittance|
|US7419483||Feb 9, 2004||Sep 2, 2008||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Surgical drain with positioning and protective features|
|US7753902 *||Nov 17, 2006||Jul 13, 2010||Hebah Noshy Mansour||Methods and devices for tissue monitoring|
|US8406868||Apr 26, 2011||Mar 26, 2013||Medtronic, Inc.||Therapy using perturbation and effect of physiological systems|
|US8423134||Apr 26, 2011||Apr 16, 2013||Medtronic, Inc.||Therapy using perturbation and effect of physiological systems|
|US8620425||Jul 30, 2010||Dec 31, 2013||Medtronic, Inc.||Nerve signal differentiation in cardiac therapy|
|US8639327||Jul 30, 2010||Jan 28, 2014||Medtronic, Inc.||Nerve signal differentiation in cardiac therapy|
|US8706223||Jan 19, 2012||Apr 22, 2014||Medtronic, Inc.||Preventative vagal stimulation|
|US8718763||Jan 19, 2012||May 6, 2014||Medtronic, Inc.||Vagal stimulation|
|US8725259||Jan 19, 2012||May 13, 2014||Medtronic, Inc.||Vagal stimulation|
|US8781582||Jan 19, 2012||Jul 15, 2014||Medtronic, Inc.||Vagal stimulation|
|US8781583||Jan 19, 2012||Jul 15, 2014||Medtronic, Inc.||Vagal stimulation|
|US8888699||Apr 26, 2011||Nov 18, 2014||Medtronic, Inc.||Therapy using perturbation and effect of physiological systems|
|US9155893||Apr 22, 2014||Oct 13, 2015||Medtronic, Inc.||Use of preventative vagal stimulation in treatment of acute myocardial infarction or ischemia|
|US20040230118 *||Feb 9, 2004||Nov 18, 2004||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Ca||Surgical drain with sensors for monitoring internal tissue condition|
|US20040230132 *||Feb 9, 2004||Nov 18, 2004||Alfred E. Mann Institute For Biomedical Engineering At The||Surgical drain with positioning and protective features|
|US20040254431 *||Feb 9, 2004||Dec 16, 2004||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Ca||Surgical drain with sensors for monitoring internal tissue condition by transmittance|
|US20040254432 *||Feb 9, 2004||Dec 16, 2004||Alfred E. Mann Institute For Biomedical Engineering At The Univ. Of S. California||Surgical drain with sensors for differential monitoring of internal condition|
|US20050227361 *||May 9, 2003||Oct 13, 2005||Michael Kratzer||Method for investigating the thrombocyte function of the blood|
|US20060161055 *||Dec 19, 2005||Jul 20, 2006||Critisense, Ltd.||Probe design|
|US20060217684 *||May 26, 2006||Sep 28, 2006||Alfred E. Mann Institute For Biomedical Engineering||Surgical Drain with Sensors for Monitoring Internal Tissue Condition|
|US20060217685 *||May 26, 2006||Sep 28, 2006||Alfred E. Mann Institute For Biomedical Engineering||Surgical Drain with Sensors for Monitoring Internal Tissue Condition|
|EP0093927A1 *||Apr 23, 1983||Nov 16, 1983||Firma Carl Zeiss||Spectral measuring device for use in blood vessels|
|EP0301323A1 *||Jul 13, 1988||Feb 1, 1989||Siemens Aktiengesellschaft||Catheter with a built-in probe for implantation in the heart|
|WO1986000207A1 *||Jun 25, 1985||Jan 16, 1986||Evans John M||Method and apparatus for measuring blood oxygen levels|
|WO1993006772A1 *||Sep 14, 1992||Apr 15, 1993||Optex Biomedical Inc||Method and apparatus for measuring blood parameters|
|WO1997012210A1 *||Dec 14, 1995||Apr 3, 1997||Swee Chuan Tjin||Fiber optic catheter for accurate flow measurements|
|WO2001003598A1 *||Jul 7, 2000||Jan 18, 2001||Hutchinson Technology||Naso-gastric reflectance spectroscopy probe|
|WO2007072424A2 *||Dec 19, 2006||Jun 28, 2007||Critisense Ltd||Optical probe design|
|U.S. Classification||600/325, 356/241.1, 600/582|
|International Classification||A61M23/00, A61B5/00, A61B1/00|
|Cooperative Classification||A61B1/00165, A61B5/1459|
|European Classification||A61B5/1459, A61B1/00S2|
|May 20, 1982||AS||Assignment|
Owner name: WARNER LAMBERT COMPANY, 201 TABOR ROAD, MORRIS PLA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN OPTICAL CORPORATION,;REEL/FRAME:004034/0681
Effective date: 19820513
Owner name: WARNER LAMBERT TECHNOLOGIES, INC.; 6373 STEMMONS F
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:WARNER LAMBERT COMPANY;REEL/FRAME:004034/0700
Effective date: 19820514